Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -35.66% is 33% below its 2-year average of -26.75%, near the low end of its 2-year range (-37.19%–-18.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 23.11% below its 12-month average of -28.96%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -35.66%.
RETURN ON INVESTED CAPITAL (ROIC)
-35.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-28.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-23.11%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-0.03%
vs the sector median at left
Rapport Therapeutics, Inc. Common Stock
Market Cap
$1.47B
Return on Invested Capital (ROIC)
-35.66%
TTM Avg
-28.96%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.47B
Return on Invested Capital (ROIC)
-19.87%
TTM Avg
-24.87%
3Y Avg
-20.19%
5Y Avg
-15.68%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
-28.63%
TTM Avg
-6.26%
3Y Avg
-69.26%
5Y Avg
-69.26%
Market Cap
$1.49B
Return on Invested Capital (ROIC)
11.91%
TTM Avg
9.57%
3Y Avg
7.02%
5Y Avg
7.35%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
0.59%
TTM Avg
0.35%
3Y Avg
-0.10%
5Y Avg
-0.25%
Market Cap
$1.44B
Return on Invested Capital (ROIC)
-53.48%
TTM Avg
-44.88%
3Y Avg
-46.83%
5Y Avg
-39.47%
Market Cap
$1.44B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.51B
Return on Invested Capital (ROIC)
20.41%
TTM Avg
-2.25%
3Y Avg
-13.09%
5Y Avg
-29.56%
Market Cap
$1.52B
Return on Invested Capital (ROIC)
33.76%
TTM Avg
23.76%
3Y Avg
-16.29%
5Y Avg
5.45%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. Common Stock (RAPP) | $1.47B | -35.66% | -28.96% | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.47B | -19.87% | -24.87% | -20.19% | -15.68% |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -28.63% | -6.26% | -69.26% | -69.26% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.49B | 11.91% | 9.57% | 7.02% | 7.35% |
| Certara, Inc. (CERT)vs › | $1.46B | 0.59% | 0.35% | -0.10% | -0.25% |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -53.48% | -44.88% | -46.83% | -39.47% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 16.83% | 6.43% | 6.32% | 5.53% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 20.41% | -2.25% | -13.09% | -29.56% |
| Nutex Health, Inc. (NUTX)vs › | $1.52B | 33.76% | 23.76% | -16.29% | 5.45% |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.42B | -34.46% | -51.53% | -88.71% | -79.79% |
ROIC
-35.7%
ROE
-32.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -35.66% |
| 2026-03-31 | -25.48% |
| 2025-12-31 | -25.36% |
| 2025-09-30 | -21.13% |
| 2025-06-30 | -37.19% |
| 2025-03-31 | -31.80% |
| 2024-12-31 | -27.13% |
| 2024-09-30 | -22.94% |
| 2024-06-30 | -18.42% |
| 2024-03-31 | -24.48% |
| 2023-12-31 | -24.68% |
